Liminatus Pharma LIMN Balance Sheet (2024-2026)

NASDAQ LIMN
$0.11 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT
Balance Sheet Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter) 0.03M0.05M0.06M0.03M0.72M0.34M
Receivables - Other (Quarter) 0.13M0.13M0.13M
Prepaid Assets (Quarter) 0.16M0.44M0.48M0.16M0.87M
Current Assets (Quarter) 5.28M1.78M1.20M0.50M2.78M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 941.00198.000.01M0.01M0.01M
Non-Current Assets (Quarter) 0.13M0.13M0.14M0.01M0.01M
Assets (Quarter) 5.41M1.91M1.34M0.51M2.79M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 1.48M0.43M0.56M0.58M0.53M
Notes Payables (Quarter) 2.80M2.80M19.97M0.45M1.44M1.44M1.44M1.44M
Payables (Quarter) 2.80M2.80M21.46M0.45M1.87M2.00M2.02M1.97M
Accumulated Expenses (Quarter) 805.000.00M
Other Accumulated Expenses (Quarter) 0.20M0.17M0.18M0.21M0.19M
Short term Debt (Quarter) 2.80M2.80M19.97M0.21M1.44M1.44M1.44M1.44M
Total Current Liabilities (Quarter) 24.75M10.52M2.86M10.30M2.89M
Non-Current Liabilities
Other Non-Current Liabilities (Quarter) 0.20M0.12M0.03M0.03M
Total Non-Current Liabilities (Quarter) 10.52M2.86M10.30M2.89M
Total Liabilities (Quarter) 24.75M0.00M10.72M2.99M10.33M2.92M
Shareholder's Equity
Total Debt (Quarter) 2.80M2.80M19.97M0.21M1.44M1.44M1.44M1.44M
Common Equity (Quarter) -18.51M-19.11M-19.34M-19.67M-8.81M-1.65M-9.81M-0.13M
Liabilities and Shareholders Equity (Quarter) 5.41M1.91M1.34M0.51M2.79M
Retained Earnings (Quarter) -28.67M-0.00M20.07M-30.70M-38.87M-40.00M